Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)

Connell, 1958 Marsh, 1950, J. Pharmacol. Exp. Ther., 100, 298 Harris, 1957, Proc. Soc. Exp. Biol. Med., 95, 212, 10.3181/00379727-95-23170 Shulgin, 1969, Nature, 221, 537, 10.1038/221537a0 Shulgin, 1975, J. Med. Chem., 18, 1201, 10.1021/jm00246a006 Shulgin, 1971, Pharmacology, 5, 103, 10.1159/000136181 Shulgin, 1978, The Psychopharmacology of Hallucinogens, 74 Alles, 1959, Neuropharmacology, Transactions of the Fourth Conference, 181 Naranjo, 1967, Med. Pharmacol. Exp., 17, 359 Shulgin, 1964, Experientia, 20, 366, 10.1007/BF02147960 Braun, 1978, QuaSAR Research Monograph 22, 27 Hauschild, 1938, Arch. Exp. Pathol. Pharmacol., 191, 465, 10.1007/BF01998844 Vree, 1973 Shulgin, 1978, Handbook of Psychopharmacology, 243 Borch, 1971, J. Am. Chem. Soc., 93, 2897, 10.1021/ja00741a013 Fairchild, 1963 Biniecki, 1960, Acta Pol. Pharm., 17, 421 Bailey, 1975, J. Assoc. Offic. Anal. Chem., 58, 62 U. Braun, A. T. Shulgin, and G. Braun, Arzneim.-Forsch., in press. Hardman, 1973, Toxicol. Appl. Pharmacol., 25, 299, 10.1016/S0041-008X(73)80016-X Yensen, 1976, J. Nerv. Ment. Dis., 163, 233, 10.1097/00005053-197610000-00002 Anderson, 1978, QuaSAR Research Monograph 22, 8 Naranjo, 1973, 26